Cargando…

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature

Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease. Understanding of PAH prevalence remains limited, but PAH has been reported as a frequent complication in connective tissue diseases. This study estimated prevalence of PAH in patients with connective tissue diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaoqin, Mardekian, Jack, Sanders, Kafi N., Mychaskiw, Marko A., Thomas, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778216/ https://www.ncbi.nlm.nih.gov/pubmed/23780636 http://dx.doi.org/10.1007/s10067-013-2307-2

Ejemplares similares

Assessment of measurement properties of peak VO(2) in children with pulmonary arterial hypertension
por: Cappelleri, Joseph C, et al.
Publicado: (2012)

Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
por: Berger, Ariel, et al.
Publicado: (2014)

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients
por: Cavagna, Lorenzo, et al.
Publicado: (2016)

Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney disease
por: Iyer, Neeraj N, et al.
Publicado: (2018)

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
por: Grünig, Ekkehard, et al.
Publicado: (2012)

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
por: Gaine, Sean, et al.
Publicado: (2017)

Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Moccaldi, Beatrice, et al.
Publicado: (2023)

The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease
por: Xiong, Jiangbiao, et al.
Publicado: (2022)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2023)

Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease
por: Niklas, Karolina, et al.
Publicado: (2018)

Evaluation of pulmonary arterial pressure in patients with connective tissue disease‐associated pulmonary arterial hypertension by myocardial perfusion imaging
por: Wang, Zengyan, et al.
Publicado: (2021)

Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials
por: Kuwana, Masataka, et al.
Publicado: (2013)

Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2021)

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
por: Dong, Xingbei, et al.
Publicado: (2022)

Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension
por: Tam, Angela Y.Y., et al.
Publicado: (2021)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Clapham, Katharine R., et al.
Publicado: (2020)

Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension
por: Nakayama, Kazuhiko, et al.
Publicado: (2021)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Effect of Th17 and Treg Axis Disorder on Outcomes of Pulmonary Arterial Hypertension in Connective Tissue Diseases
por: Gaowa, Saren, et al.
Publicado: (2014)

Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: van Uden, Denise, et al.
Publicado: (2019)

Clinical Value of Asymmetrical Dimethylarginine Detection in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Liu, Juan, et al.
Publicado: (2019)

Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide
por: Sugawara, Eri, et al.
Publicado: (2017)

Quality of life in ambulatory pulmonary arterial hypertension in connective tissue diseases and its relationship with risk stratification
por: Shi, Yue, et al.
Publicado: (2021)

Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases
por: Bellan, Mattia, et al.
Publicado: (2022)

Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
por: Sitbon, Olivier, et al.
Publicado: (2014)

Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease
por: Jin, Yansheng, et al.
Publicado: (2023)

Prevalence of pulmonary arterial hypertension in the Colombian Caribbean
por: Miranda-Machado, Pablo, et al.
Publicado: (2019)

Pulmonary hypertension in connective tissue diseases, new evidence and challenges
por: Vonk, Madelon C., et al.
Publicado: (2020)

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders
por: Bellan, Mattia, et al.
Publicado: (2019)

2020 Chinese Expert-based Consensus on the Diagnosis and Treatment of Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Zhao, Jiuliang, et al.
Publicado: (2021)

Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag
por: Tsang, Yuen, et al.
Publicado: (2023)

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)
por: Tsang, Yuen, et al.
Publicado: (2023)

The Role of Anti-U1 RNP Antibody in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Xiang, Weizhen, et al.
Publicado: (2022)

Prevalence and Pattern of Pulmonary Manifestation in Patients with Connective Tissue Disorder
por: Dahani, Assadullah, et al.
Publicado: (2020)

Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review
por: Leber, Laurence, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hvq8di4oo2iqs5i6bo37gm0rbs